Kenvue, the Johnson and Johnson spinoff that sells Tylenol, issued a statement on Tuesday against US President Donald Trump linking the painkiller with autism, saying there is “no credible science” behind it.
News for you 247
Kenvue, the Johnson and Johnson spinoff that sells Tylenol, issued a statement on Tuesday against US President Donald Trump linking the painkiller with autism, saying there is “no credible science” behind it.